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terminal pancreatic portion of the cyst 12 years
after excision [4]. Complete cyst excision can be
safely performed in nearly all cases and is now
well established as the treatment of choice for
choledochal cysts. A good case can be made to
extend total excision to include the intrapancrea-
tic portion of the cyst without fear of pancreatic
duct damage. The entire cyst is removed thereby
eliminating the chance of later malignancy.
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ABSTRACT
Sato, M., Watanabe, Y., Ueda, S., Iseki, S., Abe, Y., Sato,
N., Kimura, S., Okubo, K. and Onji, M. (1996) Microwave
coagulation therapy for hepatocellular carcinoma. Gastro-
enterology; 110, 1507-1514.
Background and Aims: Surgical resection is not
always feasible in patients with hepatocellular
carcinoma. Microwave coagulation therapy has been
used as an alternative to resection, and its efficacy
has been evaluated.
Methods: Nineteen patients with unresectable he-
patocellular carcinoma underwent microwave coa-
gulation therapy through laparotomy (n=12),
laparoscopy (n=5), or thoracotomy (n=2) because of
advanced liver cirrhosis and/or intrahepatic metas-
tases. One nodule was treated in 13 patients, and
two to five nodules were treated in 6 patients; tumor
size ranged from 5 to 90 mm. Patient outcomes were
studied.
Results: Microwave coagulation therapy created a
reproducible regional necrosis. Fourteen patients
underwent potentially curative treatment; the re-
maining 5 patients underwent palliative treatment
(n 4) or incomplete tumor coagulation (n 1). Of
the 31 nodules treated, 28 underwent complete
tumor ablation. Only 2 patients undergoing laparo-
scopic microwave coagulation therapy developed
local recurrence. The coagulated area subsequently
shrank. Patients showed rapid recovery without
hepatic dysfunction. Thirteen patients, including 2
long-term survivors, are alive either without tumor
(n=10; 14 -64 months) or with tumor (n 3; 17 22
months). Six patients died of hepatocellular carci-
noma (n=4) or liver insufficiency (n=2).
Conclusions: This preliminary study suggests the
efficacy of microwave coagulation therapy, includ-
ing safety and potential curability, in patients with
hepatocellular carcinoma with advanced liver cir-
rhosis and multifocal or central tumors.
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PAPER DISCUSSION
Hyperthermia has been employed clinically as
one of a variety of multi-modal therapies for
malignancies. There is increasing evidence to
support the hypothesis that cancer cells are more
sensitive to heat than normal cells possibly due to
alterations in blood supply in neoplastic tissue
and a decreased ability for neovascular beds to64 HPB INTERNATIONAL
vasodilate. Regional and systemic hyperthermic
therapies have many technical and physiological
disadvantages over local treatment.
Cautery or coagulative necrosis is produced
by a variety of modalities and has long been
used as a means of destroying malignant tissues
in situ. Modern electrical use of alternating
current for coagulation was popularized by
Harvey Cushing and W.T. Bovie in 1928.
However, coagulation (charring of tissues) tends
to limit the heat distribution and size of
destruction by increasing tissue impedance. If
tissue temperature is kept below 100C, con-
ductive heating spreads over a larger area.
The recent interest in radiofrequency (RF)
ablation (high frequency alternating current)
stems from two concepts. One, tumors can be
destroyed in situ without the traditional resec-
tion for cure, thus potentially reducing the
morbidity and mortality associated with major
liver resections. Two, small tumors if destroyed,
have a curative potential and if cure is not
possible, there may be a palliative benefit in
reducing tumor volume.
Radiofrequency ablation combines the two
concepts of cell death via heating the tissues to
lethal temperatures (>70C for 5 min) and
coagulation necrosis in the center of the lesion
and the needle tract, reducing bleeding from the
tract. Current RF probes are small diameter (15
French) and some probes have multiple retract-
able hooks each of which contains an active
electrode and a thermistor to monitor tissue
temperature, and provide a predictable spheri-
cal zone of tissue destruction.
Cryotherapy ablation functions in a similar
fashion but the technology is more expensive,
cumbersome, and the treatment times tend to be
significantly longer. Alcohol injection has been
successful in treating small hepatocellular carci-
nomas, but its use is limited in larger primary
tumors and desmoplastic metastases, where the
tissue permeability with alcohol is unreliable. As
in cryoablation, RF has the disadvantage of the
heat sink where high volume blood flow
removes heat, which may protect malignant
cells adjacent to major blood vessels such as
hepatic veins. This potential problem may be
reduced with the addition of alcohol injection
through the hollow RF needle.
Sato, et al., have shown RF destroys tissues
several centimetres in diameter using an open
technique and several applications. This techni-
quemaybe effective in patientswhowouldnorm-
ally not be resection candidates. However, the RF
technology may provide its greatest advantage in
treating smaller tumors, for shorter durations
using a percutaneous or laparoscopic approach.
These patients can be treated as out patients thus
maximizing the potential for debulking tumors,
reducing medical costs, and potentially prevent-
ing a major surgical procedure with significant
impacts on the patient’s well being.
RF is a new technology which has great
potential in adding to the already expanding
field of tumor ablation. With greater world
experience, RF’s place will become clear.
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